Bentham Science Logo

Track Your Manuscript:

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research


Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 10 - Number 3

Metabolic Acidosis in Sepsis

, 10(3): 252 - 257

Alexandre Toledo Maciel, Danilo Teixeira Noritomi and Marcelo Park

DOI: 10.2174/187153010791936900

Lipid-Activated Nuclear Receptors and Sepsis

, 10(3): 258 - 265

Thais Martins de Lima-Salgado, Luiz Monteiro Cruz and Heraldo Possolo Souza

DOI: 10.2174/187153010791936937

Corticosteroids in Sepsis: Pathophysiological Rationale and the Selection of Patients

, 10(3): 266 - 273

Jorge Ibrain Figueira Salluh, Fernando Augusto Bozza, Andre Miguel Japiassu, Hugo Caire Castro Faria Neto, Patricia Torres Bozza and Pedro Povoa

DOI: 10.2174/187153010791936865


Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”

View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations

Society Name: The official Journal of Associazione Medici Endocrinologi


How to write and publish your papers in high impact journalsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog